Effect of ayurveda-based panchakarma and lifestyle modification on global longitudinal strain in cardiac disorder patients

Priti S. Muramkar; Nilesh Kulthe; Pravin Ghadigaonkar

doi:10.18203/2349-3933.ijam20243059

Authors

Priti S. Muramkar Madhavbaug Cardiac Care and Clinic, Ghatkopar, Maharashtra, India
Nilesh Kulthe Department of Medical, Madhavbaug Cardiac Care and Clinic, Thane, Maharashtra, India
Pravin Ghadigaonkar Department of Medical, Madhavbaug Cardiac Care and Clinic, Thane, Maharashtra, India

DOI:

https://doi.org/10.18203/2349-3933.ijam20243059

Keywords:

Ayurveda, Global longitudinal strain, Panchakarma, Vo2 max

Abstract

Background: The present sought to study the change in global longitudinal strain (GLS) after 90 days in known cases of cardiac disorders with Ayurveda based Panchakarma and lifestyle modification.

Methods: A retrospective, observational, single-centre study was conducted from July 2021 to April 2022 in Maharashtra, India. Patients aged 18 years and above, diagnosed with inducible ischemia on stress test who underwent the ischemia reversal program (IRP) included in this study. Follow-up was conducted at 90 days. Day 1 and day 90 data were compared.

Results: A total of 32 patients were assessed. Anthropometric variables such as weight (day1: 68.31±12.40 kg and day 90: 63.82±10.93 kg, p=0.00) and abdominal girth (day 1: 93.56±9.60 cm and day 90: 88.22±6.19 cm, p=0.00) improved at the 90-day follow-up. The lipid profile also improved for variables such as high-density lipoprotein (day 1: 27.66±2.69 mmol/l and day 90: 31.94±2.69 mmol/l, p=0.00), low-density lipoprotein (day 1: 146.88 ± 44.68 mmol/l and day 90: 102.00±9.10 mmol/l, p=0.00), and triglycerides (day 1: 206.03±43.41 mmol/l and day 90: 157.53±35.70 mmol/l, p=0.00). Vo2 max changed from 16.93 ± 7.87 ml/kg/min to 30.83±3.76 ml/kg/min, p=0.00). GLS improved from -14.08±3.79 to -16.35±3.26.

Conclusion: Panchakarma therapy and lifestyle modifications help in improving global longitudinal strain, reducing symptoms of chest pain, breathlessness, dyspnea on exertion, improved V02 peak and improved weight loss and ejection fraction.

Metrics

Metrics Loading ...

References

Kiran G, Mohan I, Kaur M, Ahuja S, Gupta S, Gupta R. Escalating ischemic heart disease burden among women in India: Insights from GBD, NCDRisC and NFHS reports. Am J Prev Cardiol. 2020;2:100035.

Paulose RM, Arivazhahan A. Treatment of ischemic heart disease. Introduction to basics of pharmacology and toxicology. Springer, Singapore. 2021;14:421-34.

Pello Lázaro AM, Blanco-Colio LM, Franco Peláez JA, Tuñón J. Anti-inflammatory drugs in patients with ischemic heart disease. J Clin Med. 2021;10(13):2835.

Mandole R, Amin G, Ghadigaonkar P, Narang R. Study of the efficacy of ischemia reversal program along with restricted diet in an elderly myocardial ischemic patient with a known history of hypertension - A case study. Inter J Ayur Pharma Res. 2023;11(4):79-82.

General assembly of the world medical association. world medical association declaration of helsinki: ethical principles for medical research involving human subjects. J Am Coll Dent 2014; 81(3):14-8.

Dixon JR. The International conference on harmonization good clinical practice guideline. Qual Assur 1998; 6(2):65-74.

Sane R, Manohar P, Mandole R, Amin G, Ghadigaonkar P, Dongre S, et al. Impact of ayurveda based ischemia reversal program (IRP) and polyherbal medication on reduction of resting myocardial ischemia with speckle tracking global longitudinal strain imaging in type 2 diabetes mellitus patients. Int J Innov Res Med Sci. 2022;7(8):416-9.

Sane R, Mandole R, Amin G, Ghadigaonkar P, Yanshwantrao P, Jadhav R.The impact of ayurveda-based ischemia reversal program (IRP) and Poly-herbal medication on reduction of resting myocardial ischemia. Asian J Cardiol Res. 2023;6(1):190-6.

Sane R, Sugwekar V, Nadapude A, Hande A, Depe G, Mandole R. Study of efficacy of ischemia reversal program (IRP) in ischemic heart disease (IHD) patients with VO2max and Duke’s treadmill score. Inter J Basic Clin Pharmacol. 2003;7(8):1642-7.

Sane R, Gond B, Raje G, Walzade K, Badre A, Mandole R. Ischemia reversal program (IRP) in patients suffering from ischemic heart disease (IHD) with known history of hypertension: A retrospective study. J Ayur Med Sci. 2018;3(2):377-83.

Sane S, Wadekar A, Shinde K, Furia H, Upadhyay P, Mandole R. Understanding the role of ayurveda based ischemia reversal program and low carbohydrate diet in reduction of risk of heart disease. Asian J Cardiol Res. 2019;2(1):1-8.

Sane R, Ghadigaonkar P, Kharat A, Yadav KS, Mahajan S, Mandole R. Efficacy of ischemia reversal program (IRP) in elderly patients of ischemic heart disease with known history of hypertension. Asian J Cardiol Res. 2018;1(1):1-8.

Rohit S, Rahul M, Amin G, Ghadigaonkar P. Impact of change in maximum aerobic capacity in patients with coronary artery disease: 36 months follow up. J Cardiovas Dis Diag. 2020;8(2):4.

Sane R, Manohar, Mandole R, Amin G, Ghadigaonkar A. Role of ischemia reversal program to reduce myocardial ischemia studied with cardiac stress testing: an observational study. European Journal of Pharmaceutical and Medical Research 2021;8(12):441-7.